Objective: The purpose of the present study was to gain a comprehensive view of the quality of life and socio-economic conditions in a more representative sample of patients with diastrophic dysplasia than previously presented.
Methods: The study sample comprised 115 patients with diastrophic dysplasia, aged over 18 years. The patients were contacted, and 68 patients (59%) agreed to participate in the study. They answered a structured questionnaire, which included the items of RAND-36 and Finn-Health Assessment Questionnaire (Finn-HAQ) questionnaires. The Finn-HAQ items were linked to the categories of the International Classification of Functioning, Disability and Health (ICF). Population controls for matching the participating patients for age and sex were identified in the Finnish population registry. Demographic and social factors (educational status, employment status and household income) were collected in separated questions.
Results: RAND-36 showed significantly lower physical functioning in the group of diastrophic dysplasia patients than in the control group. Also, the differences in scores for energy and social functioning were significant. In the mental component scales, no significant difference was found between the groups. When compared with the controls, we found significantly lower levels in all 3 ICF components of functioning in the group of patients when Finn-MDHAQ items linked to ICF were used. Almost 75% of patients with diastrophic dysplasia belonged to the group of people with minor/low income. Some or clear worsening of economic situation due to diastrophic dysplasia was reported by 25 (58%) female and 17 (68%) male patients.
Conclusion: In their daily living, patients with diastrophic dysplasia have marked physical difficulties, which affect their quality of life, participation in society and their financial situation. It seems that the mental situation is not greatly affected, but a more detailed study is needed to evaluate and illuminate the psychological consequences of this severe skeletal dysplasia. Overall, the pieces of information in the present study are of high importance when designing and reorganizing rehabilitation and in supportive therapy and treatment of patients with diastrophic dysplasia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2340/16501977-1116 | DOI Listing |
Dis Model Mech
December 2024
Department of Orthodontics and Dentofacial Orthopedics, Osaka University Graduate School of Dentistry, Osaka 565-0871, Japan.
The sulfate transporter gene SLC26A2 is crucial for skeletal formation, as evidenced by its role in diastrophic dysplasia, a type of skeletal dysplasia in humans. Although SLC26A2-related chondrodysplasia also affects craniofacial and tooth development, its specific role in these processes remains unclear. In this study, we explored the pivotal roles of SLC26A2-mediated sulfate metabolism during tooth development.
View Article and Find Full Text PDFAnaesthesiologie
October 2024
Klinik für Gynäkologie und Geburtshilfe, St. Elisabeth-Hospital Bochum, Ruhr-Universität Bochum, Bochum, Deutschland.
Clin Case Rep
October 2023
División de Estudios de Posgrado de la Facultad de Medicina, Universidad Nacional Autónoma de México/Departamento de Genética Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City Mexico.
Diastrophic dysplasia (DTD) is caused by biallelic pathogenic variants in the gene. We report the case of a 49-year-old female with DTD and esophageal stenosis. This broadens the phenotypic spectrum in adult patients with DTD and raises awareness of extra-skeletal manifestations that could develop in later stages of life.
View Article and Find Full Text PDFFront Genet
September 2023
Center for Fetal Diagnostics, Aarhus University, Aarhus, Denmark.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!